Evidence map›Paper›PMID 29549646›Full record

ArticleMolecular neurobiology2018

NTF3 Is a Novel Target Gene of the Transcription Factor POU3F2 and Is Required for Neuronal Differentiation.

Yi-Mei J Lin, I-Lun Hsin, H Sunny Sun, Shankung Lin, Yen-Ling Lai, Hsuan-Ying Chen, Ting-Yu Chen, Ya-Ping Chen, Yi-Ting Shen, Hung-Ming Wu

Open access · hybridAbstract read
In one paragraph

Article in Molecular neurobiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 51 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Sex differences in DNA methylation in bats.Annals of the New York Academy of Sciences · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. ASCL1 promotes Scrt2 expression in the neural tube.Frontiers in cell and developmental biology · 2024
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Yi-Mei J LinInstitute of Biomedical sciences, National Chung Hsing University, Taichung City, Taiwan.
I-Lun HsinInflammation Research & Drug Development Center, Changhua Christian Hospital, No. 135 Nanxiao Street, Changhua, 500, Taiwan.
H Sunny SunInstitute of Molecular Medicine, National Cheng Kung University, Tainan, Taiwan.
Shankung LinInflammation Research & Drug Development Center, Changhua Christian Hospital, No. 135 Nanxiao Street, Changhua, 500, Taiwan.
Yen-Ling LaiInflammation Research & Drug Development Center, Changhua Christian Hospital, No. 135 Nanxiao Street, Changhua, 500, Taiwan.
Hsuan-Ying ChenInflammation Research & Drug Development Center, Changhua Christian Hospital, No. 135 Nanxiao Street, Changhua, 500, Taiwan.
Ting-Yu ChenInflammation Research & Drug Development Center, Changhua Christian Hospital, No. 135 Nanxiao Street, Changhua, 500, Taiwan.
Ya-Ping ChenInflammation Research & Drug Development Center, Changhua Christian Hospital, No. 135 Nanxiao Street, Changhua, 500, Taiwan.
Yi-Ting ShenInstitute of Biomedical sciences, National Chung Hsing University, Taichung City, Taiwan.
Hung-Ming WuInflammation Research & Drug Development Center, Changhua Christian Hospital, No. 135 Nanxiao Street, Changhua, 500, Taiwan. 18288@cch.org.tw.ORCID http://orcid.org/0000-0003-4042-7132
Changhua Christian Hospital · TWNational Chung Hsing University · TWChina Medical University · TWNational Cheng Kung University · TW

Funding

National Science Council NSC100-2314-B-371-004National Science Council NSC 101-2314-B-371-006-MY3
6 · The paper itself

Abstract

POU-homeodomain transcription factor POU3F2 is a critical transcription factor that participates in neuronal differentiation. However, little is known about its downstream mediators. Here genome-wide analyses of a human neuronal differentiation cell model, NT2D1, suggested neurotrophin-3 (NTF3), a key mediator of neuronal development during the early neurogenic period, as a putative regulatory target of POU3F2. Western blot, cDNA microarray, and real-time quantitative PCR analyses showed that POU3F2 and NTF3 were upregulated during neuronal differentiation. Next-generation-sequence-based POU3F2 chromatin immunoprecipitation-sequencing and genome-wide in silico prediction demonstrated that POU3F2 binds to the NTF3 promoter during neuronal differentiation. Furthermore, unidirectional deletion or mutation of the binding site of POU3F2 in the NTF3 promoter decreased promoter-driven luciferase activity, indicating that POU3F2 is a positive regulator of NTF3 promoter activity. While NTF3 knockdown resulted in decreased viability and differentiation of NT2D1 cells, and POU3F2 knockdown downregulated NTF3 expression, recombinant NTF3 significantly rescued viable neuronal cells from NTF3- or POU3F2-knockdown cell cultures. Moreover, immunostaining showed colocalization of POU3F2 and NTF3 in developing mouse neurons. Thus, our data suggest that NTF3 is a novel target gene of POU3F2 and that the POU3F2/NTF3 pathway plays a role in the process of neuronal differentiation.

Indexed as

Cell DifferentiationAnimalsBase SequenceFemaleGene SilencingHomeodomain ProteinsHumansMice, Inbred C57BLNerve Tissue ProteinsNeuronsNeurotrophin 3POU Domain FactorsPromoter Regions, GeneticProtein BindingRecombinant ProteinsTranscriptional ActivationHomeodomain ProteinsNerve Tissue ProteinsNeurotrophin 3Pou3f2 protein, mousePOU Domain FactorsRecombinant Proteinstranscription factor Brn-2Neuron differentiationNeurotrophin 3POU3F2

Identifiers

PMID29549646
PMCPMC6153716
OpenAlexW2792876614

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.